IDEVAX

Startup

Idevax is an ISO13845 certified Belgian medical device company specialising in innovative drug delivery solutions for prophylactic and therapeutic applications. Our flagship product line, VAX-ID®, is a CE-marked device suited for reliable, standardized, and user-independent skin drug delivery with minimal training and high degree of ease of use. 

VAX-ID® is designed to support a broad spectrum of applications, including cell and gene therapies, ATMPs, and immunotherapies, such as cancer vaccines. With its unique ability to consistently deliver into the dermis, it offers important advantages such as enhancing immune response, supporting patient compliance, and potentially transforming therapy accessibility. 

  At Idevax, we are dedicated to empowering researchers, clinicians, and industry stakeholders including NGOs, biotechs, big pharma and KOLs, in their mission to develop and deploy life-changing therapies. 

  Visit our website (www.idevax.com) or follow our LinkedIn page to discover how Idevax’s innovative solutions are driving the future of biologics and improving patient outcomes worldwide. We look forward to connecting with you ahead of the Festival of Biologics 2025—let’s shape the future of therapy delivery together!